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Abstract Article Info 
Introduction: Nasopharyngeal carcinoma is common in China and Southeast Asia, including Indonesia. The 
cases are often diagnosed in an advanced  stage with a poor prognosis.  
Objective: The purpose of this study was to determine the incidence of anemia in nasopharyngeal carcinoma 
patients in the ENT-HNS Department West Nusa Tenggara Hospital.  
Methods: the methods of this research are a descriptive study that used data from the medical record of West 
Nusa Tenggara  Hospital. The data were obtained between April 2017 to September 2017. 
Result: During the study periods, we obtained  32 cases.  75% of patients were male and 25% female, with ratio 
3:1. According to the age, patients were distributed from 28 to 69 years old with peak incidence at 41-60 years 
old. Most patients were stage IV (68.75%). There was 87.51% patient with anemia in this research. However,the 
highest number was found mild anemia 59.38% and the most types of anemia were hypochromic microcytic. 
Discussion: In this study, patients with advanced stages were 93.75%, consist of stage IV (68.75%) and stage 
III (25%), followed by stage II 6.25%, while stage I was not found. This shows that patients usually come at an 
advanced stage because of the low awareness of the NPC in medical personnel in Indonesia. 
Conclusion: The incidence of anemia in a patient with nasopharyngeal cancer in West Nusa Tenggara Hospital 
is 87.51%. Most of them were mild grade and hypochromic microcytic type. 
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1. INTRODUCTION 
Nasopharyngeal carcinoma (NPC) is a carcinoma that appears in the 
nasopharynx (the area above the throat and behind the nose), which shows 
the evidence that there is a mild or ultrastructural squamous differentiation 
microscopically [1]. 
 In Indonesia, NPC is the 4th most malignancy after breast cancer, 
cervical cancer, and lung cancer. Based on GLOBOCAN 2012 [2], there 
were 87.000 new nasopharyngeal cancer cases occur annually (with 61.000 
new cases occurring in male and 26.000 new cases in female). There were 
51.000 deaths from NPC (36.000 in male, and 15.000 in female). According 
to global cancer statistic (GLOBOCAN) 2018, there are 129.079 new cases 
worldwide or 0.7% of all cancer cases with 72.987 death due to 
nasopharyngeal cancer annually [3]. 
NPC mainly found unproductive age male (the ratio of male and female 
is 2.18: 1) and 60% of patients were aged between 25 and 60 years [4].. The 
highest incidence in the world is in the province of Southeast China with 
40-50 nasopharyngeal cancer cases among 100.000 residents. On the other 
hand, nasopharyngeal cancer is very rare in areas of Europe and North 
America with an incidence <1/100.000 population [4]. 
The causes of malnutrition in cancer patients are very complex and 
multifactorial. Serotonin and bombesin hormones which are secreted by 
tumor cells can suppress the appetite and lead to anorexia. Nasopharyngeal 
cancer can also induce the inflammation of the oral mucosa,  mucous 
membranes of the digestive tract, pain, decreased of salivary gland 
secretion, suppresses sensation and tooth decay. Decreased oral intake of 
nutrients can cause a decrease in endurance, infection and weight loss. 
Therapy for cancer also affects the nutritional status of patients. Maskoep 
(2008) on his study found that more than 40% of cancer patients who were 
treated were malnourished [5]. 
The more, unfortunately, the cases usually found in the advanced stage. 
This lead to the need for chemotherapy on its treatment. According to 
NCCN, advance nasopharyngeal cancer should be treated with a 
combination of radiotherapy and chemotherapy. Chemotherapy could be 
given in the scheme of adjuvant, neoadjuvant, concurrent or concomitantly 
[6]. Chemotherapy is one of the management of advanced nasopharyngeal 
cancer. Drugs that used in cancer therapy acting to damage, suppress and 
prevent the spread of cancer cells that grow rapidly. Chemotherapy drugs 
not only affect cancer cells but also normal cells, and in certain amounts 
may cause side effects on the oral and gastrointestinal mucosa, hair follicles, 
reproductive system, and hemopoietic system [7]. 
One of the effects of chemotherapy is the formation of free radicals 
from  cisplatinadministration [5]. Excessive free radicals are toxic, which 
may damage normal cells in the body including bone marrow cells, which 
results in the suppression of the blood cell formation system. The blood cell 
formation system has a function to produce hemoglobin [8]. 
Anemia is a common problem in cancer patients who get chemotherapy 
because it can occur as a result of cancer or as a complication of chemotherapy 
administration. As many as 67-81% of patients who received chemotherapy 
suffer from anemia. The occurrence of anemia in anticancer administration can 
cause the treatment to be less effective. The response as well as the survival to 
radiotherapy and or chemoradiotherapy can be decreased in patients who were 
received radiotherapy or chemoradiotherapy [7]. 
Anemia is a condition where the number of red blood cells or 
hemoglobin in blood cells is below normal. The main factors that are 
causing anemia are lack of iron from food intake or low levels of iron 
absorption and the presence of inhibitors. It makes the absorption is not 
optimal and led to the lower iron body's requirement [9]. 
The classification of anemia based on the US National Cancer Institute, 
divided into 5 levels. First level (level 0) normal value, male >12 g/dL, 
female >11 g/dL. Level 1 (mild) if Hb 10.0-normal value, level 2 (moderate) 
if Hb 8.0-10.0. Level 3 (severe) if Hb 6.5-7.9 and the last level (extremely 
severe) if Hb less than 6.5 [10, 11]. 
Cancer related anemia can be a result of tumor related hemorrhage, 
tumor invasion of bone marrow, malnutrition caused by tumor, abnormal 
iron metabolism, kidney function impairment and compromised bone 
marrow function under the effect of various tumor-related cytokines. In 
most cases, the condition is a normocytic normochromic anemia with 
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decreased serum iron and transferrin saturation, and normal or elevated 
serum ferritin. Bone marrow suppression is a common adverse reaction of 
chemotherapy and radiotherapy among cancer patients. The widespread use 
of cytotoxic drugs, particularly platinum-based agents, is an important 
contributing factor for tumor related anemia [12]. 
Based on the morphology of red blood cells, cancer can be classified as 
microcytic anemia (characterized by a small mean corpuscular volume 
(MCV) of <80 fl), normocytic anemia (characterized by a normal MCV of 
80-100 fl) and macrocytic anemia (characterized by a large MCV of >100 
fl). Other morphological basis for classification may include the amount of 
red blood cell hemoglobin and mean corpuscular hemoglobin: hypochromic 
(characterized by a small mean corpuscular hemoglobin (MCH) of <26 pg) 
or normochromic (characterized by a normal MCH of 26-34 pg) [13]. 
The types of anemia divided into normochromic normocytic anemia if 
anemia which occurs due to excessive blood expenditure, causing the bone 
marrow to work harder in erythropoiesis so that many young erythrocytes 
are seen on the peripheral circulation. Normochromic macrocytic anemia if 
anemia due to vitamin B12 deficiency. Hypochromic microcytic anemia if 
anemia due to iron deficiency [13]. 
2. MATERIAL AND METHODS 
The research was conduct with a descriptive study that used data from 
the medical record. The data will be taken from West Nusa Tenggara  
Hospital from April 2017 to September 2017. The study sample was data on 
patients with a diagnosis of nasopharyngeal carcinoma who treated in the 
ENT-HNS departement, West Nusa Tenggara Hospital. The data that will be 
collected including patient identity, diagnosis, the hemoglobin 
concentration from laboratory results and peripheral blood smear. The data 
then analyze descriptively. 
3. RESULT 
There were 32  patients of NPC who fulfill the study criteria, consisting 
of 75% of male and 25% of female (Table 1). According to the age category, 
patients were divided into several groups. Most of the patients were found 
in older age (41 to 60 years old)with the frequency 17 or 53.12%, followed 
by young adults  (21-<41 years old)with the frequency 9 or 28.13%. Based 
on gender, in this study, the cases wsere found mostly in male (75%) with 
the male and female ratio 3:1. 
Table 1. Frequency distribution of patients with nasopharyngeal 
carcinoma according to age and sex 
Age 
(year) 
Male Female Total 
frequency % frequency % frequency % 
< 21 - - - - - - 
21-<41 7 21.87 2 6.25 9 28.13 
41- 60 12 37.50 5 15.62 17 53.12 
>60 5 15.63 1 3.13 6 18.75 
Total 24 75 8 25 32 100 
Table 2. Distribution of patients with nasopharyngeal carcinoma based on the stage 
Stadium 
Frequency 
f 
Percentage 
% 
I - - 
II 2 6.25 
III 8 25.00 
IV A 10 31.25 
IV B 12 37.50 
IV C - - 
Total 32 100 
In table 2, patients generally come at an advanced stage; most of them 
are stage IV ( 68.75%). This case is followed by patients with stage III and 
II were found  25% and 6.25% consecutively. 
Table 3. Distribution of patients with nasopharyngeal carcinoma 
according to anaemic status (US NCI) 
Anemia Male Female Total 
    f %    f %   f % 
Normal 4 12.50 - - 4 12.50 
Mild  16 50.00 3 9.38 19 59.38 
Moderate 4 12.50 4 12.50 8 25.00 
Severe  - - 1 3.13 1 3.13 
extremely severe - - - - - - 
Total 24 75 8 25 32 100 
In the table above, patients with normal Hb was found in 4 (12.50%) 
patients, on the other hand, the most patients categorized as mild anemia 
with the frequency 19 (59.38%). In this study, we also found the cases with 
severe anemia  1 (3.13%) patients, but very severe anemia was not found. 
Table 4.      Distribution of Hb levels before and after chemotherapy 
Anemia Before Chemotherapy After Chemotherapy 
    f %    f % 
Normal 4 12.5 4 12.5 
Mild  19 59.375 27 84.375 
Moderate 8 25 1 3.125 
Severe  1 3.125 0 3.125 
extremely severe - - - - 
Total 32 100 32 100 
In this study also analyzed the Hb level before and after chemotherapy. 
According to table 4, most patients before and after chemotherapy suffered from 
mild anemia. However, there is not a significant difference between both groups. 
Table 5.      Distribution of types of anemia  based on the complete blood test 
result and peripheral blood smear 
Anemia Mild Moderate Severe 
  f % f %  f  % 
Normositik 
Normokromik  
- - 1 3.13 - - 
Makrositik 
Normokromik 
- - - - - - 
Mikrositik 
Hipokromik 
9 28.13 2 6.25 - - 
We only found the data on 12 patients. In table 5, according to complete 
blood test result most of the types of anemia was hypochromic microcytic 
11 (34.38%) and according to peripheral blood smear only1 (3.13%) patients 
with anemia normocytic normochromic. 
4. DISCUSSION 
According to the results of our study, we found a comparison of male and 
female was 3: 1. Yenita et al. (2010) on their research in West Sumatra gets a ratio 
2:1 [14]. The research in the United States has found a ratio of 2:1 [2].  NPC is 
always found higher in the male. The incidence of NPC often occurs with male 
and female ratios 3:1 [15]. It has not been found with certainty the cause of high 
male sufferers than female in this cancer. Male may be more likely to be exposed 
to carcinogens in their work environment than female so that they are more at 
risk for cancer. In this study obtained the highest age range between 41-60 years 
old, this result is similar to some literature whom 60% of patients distributed in 
the age group between 25 to 60 years old. 
In this study, patients with advanced stages were 93.75%, consist of 
stage IV (68.75%) and stage III (25%), followed by stage II 6.25%, while 
stage I was not found. This shows that patients usually come at an advanced 
stage because of the low awareness of the NPC in medical personnel in 
Indonesia. The hidden location of the tumor in the nasopharynx may lead to 
the requirements of a special examination in a hospital that has complete 
facilities. Those factors also make the early detection of this cancer 
becoming more complicates. Knowledge of the signs and symptoms that 
often arise such as nasal obstruction, epistaxis, headaches, and tinnitus is 
often considered a common cold that makes nasopharyngeal cancer 
detection is lately. The delay in diagnosis is also related to the patient's 
unconsciousness to NPC  as well as the tendency of patients to seek 
traditional medicine as the first treatment [16]. 
In cases of malignancy anemia often occurs. In this study, mild anemia 
was found which could mostly occur as a result of cancer or as a 
complication of giving chemotherapy administration. The main factors 
causing anemia are lack of iron consumption from food or low levels of iron 
absorption as well as the presence of absorption inhibitors so that it cannot 
be absorbed optimally and does not meet the body's requirments [9]. 
In this study, the patients before and after chemotherapy mostly had 
mild anemia. It happens from the beginning of the patients' diagnosis as 
NPC. It may be due to lack of nutrition and because of cancer progress.                 
The chemotherapy did not affect the decrease in Hb according to our 
data.  This may be because they were threatened to improve their 
general condition and some of them receive the blood transfusion to 
gain the Hb level [17]. 
In this study, most types of anemia are hypochromic microcytic. It 
means that the number of red blood cells or hemoglobin (an oxygen 
transport protein) in blood cells was below the normal limit and this may be 
caused by iron deficiency. Other causes of iron deficiency are insufficient 
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of iron intake, impaired absorption, persistent blood loss as in 
gastrointestinal bleeding, and neoplasms. Anemia due to iron deficiency 
occurs gradually, starting from the iron loss over the intake, reduced iron 
reserves which can not meet the requirements for the red blood cells 
production, then anemia begins. Then bone marrow tries to replace iron 
deficiency by speeding up cell division and producing red blood cells in very 
small size (microcytes). With the worsening of iron deficiency and anemia, 
symptoms will arise such as fatigue, shortness of breath, and lack of energy. 
5. CONCLUSION 
The incidence of anemia in a patient with nasopharyngeal cancer in 
West Nusa Tenggara Hospital is 87.51%. Most of them were mild grade and 
hypochromic microcytic type.  
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